Literature DB >> 6456026

Production and characterization of monoclonal antibodies to the subunits of human phosphofructokinase: new tools for the immunochemical and genetic analyses of isozymes.

S Vora, L A Wims, S Durham, S L Morrison.   

Abstract

Recently we have demonstrated that human phosphofructokinase (PFK; ATP: D-fructose-6-P, 1-phosphotransferase; EC.2.7.1.11) is under the control of three structural loci that code for M (muscle-type), L (liver-type), and P (platelet-type) subunits: random tetramerization of these subunits produces various isozymes. In this study, we have produced and characterized BALB/c hybridoma antibodies to the M- and L-type subunits of human PFK. The specific antibodies were detected by an enzyme-immunoprecipitation assay using Staphylococci-bearing protein A as an immunoadsorbent. Of the wells tested using red blood cell (RBC) PFK (M + L), 61% were positive. Only one M-specific hybridoma was identified. The one anti-M and 4 anti-L antibodies were characterized for their biochemical and immunochemical specificities. To define the combining specificities of these antibodies, we compared their reactivity and that of monospecific rabbit anti-M antiserum with muscle and liver PFKs from 15 different vertebrate species. The rabbit anti-M shows strong cross-reactivity with the muscle PFKs from all the species studied. In contrast, the monoclonal anti-M reacts exclusively with muscle PFKs from primates. Two of four anti-L antibodies react only with human L-PFK, whereas the other two react with that from a few other vertebrate species as well. Taken together, these data suggest that primate-specific antibodies recognize evolutionarily, recently acquired antigenic determinants, whereas the antibodies reactive with PFKs from distantly related species recognize conserved determinants. The differential immunoreactivities of muscle and liver PFKs strongly suggest the presence of distinct isozymes in all the vertebrate species studied. These studies demonstrate that it is feasible to produce and characterize monoclonal antibodies that distinguish among isozymes with structural and functional similarities. These antibodies provide sensitive tools in the analyses of isozyme structure, genetics, and related fields.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456026

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.

Authors:  S Vora; S DiMauro; D Spear; D Harker; M J Danon
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

Authors:  M Van Keuren; H Drabkin; I Hart; D Harker; D Patterson; S Vora
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

3.  Induction of glycolytic enzyme synthesis in proliferating fibroblasts. Study of phosphofructokinase, glucose phosphate isomerase and pyruvate kinase.

Authors:  M C Meienhofer; J C Dreyfus; A Kahn
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

4.  Monoclonal antibodies to L-asparaginase.

Authors:  T Kitao; K Hattori
Journal:  Experientia       Date:  1984-02-15

5.  Duplication of chromosome 10p: confirmation of regional assignments of platelet-type phosphofructokinase.

Authors:  S Schwartz; M M Cohen; S R Panny; J H Beisel; S Vora
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

6.  Muscle phosphofructokinase deficiency. Biochemical and immunological studies of phosphofructokinase isozymes in muscle culture.

Authors:  M Davidson; A F Miranda; A N Bender; S DiMauro; S Vora
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

7.  Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies.

Authors:  S Vora; R Oskam; G E Staal
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

8.  Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.

Authors:  S Vora; U Giger; S Turchen; J W Harvey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.

Authors:  S Vora; M Davidson; C Seaman; A F Miranda; N A Noble; K R Tanaka; E P Frenkel; S Dimauro
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Alterations in phosphofructokinase isoenzymes during early human development. Establishment of adult organ-specific patterns.

Authors:  M Davidson; M Collins; J Byrne; S Vora
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.